Ra Capital Management, L.P. Nkarta, Inc. Transaction History
Ra Capital Management, L.P.
- $6.17 Billion
- Q4 2024
A detailed history of Ra Capital Management, L.P. transactions in Nkarta, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 10,805,129 shares of NKTX stock, worth $22.2 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
10,805,129
Previous 10,805,129
-0.0%
Holding current value
$22.2 Million
Previous $48.8 Million
44.91%
% of portfolio
0.44%
Previous 0.68%
Shares
5 transactions
Others Institutions Holding NKTX
# of Institutions
120Shares Held
61.3MCall Options Held
17.6KPut Options Held
1.11M-
Black Rock Inc. New York, NY4.06MShares$8.32 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$7.72 Million2.88% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$7.32 Million0.63% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.56MShares$7.31 Million0.0% of portfolio
-
Sr One Capital Management, LP3.33MShares$6.83 Million3.09% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $99.7M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...